G
Market Data
$6.05−$0.03 (−0.493%)
GYRE · Last trade
Prev Close
$6.08
Range (29d)
$6.05 – $7.34
Recent Filings
- 8-K175.6 KBGYRE THERAPEUTICS, INC.Jul 16, 4:35 PM ET·0001140361-26-028716
- 8-K/A2.7 MBGYRE THERAPEUTICS, INC.Jul 15, 5:09 PM ET·0001140361-26-028564
- 8-K172.9 KBGYRE THERAPEUTICS, INC.Jun 16, 6:30 AM ET·0001140361-26-025324
- 8-K8.9 MBGYRE THERAPEUTICS, INC.Jun 2, 6:09 AM ET·0001140361-26-023625
- 8-K4.6 MBGYRE THERAPEUTICS, INC.May 14, 5:25 PM ET·0001140361-26-021360
- 8-K185.2 KBGYRE THERAPEUTICS, INC.May 12, 5:03 PM ET·0001140361-26-020845
- 10-Q13.5 MBGYRE THERAPEUTICS, INC.May 8, 4:16 PM ET·0001193125-26-214676
- 8-K559.9 KBGYRE THERAPEUTICS, INC.May 6, 8:30 PM ET·0001193125-26-209789
- 8-K580.3 KBGYRE THERAPEUTICS, INC.May 4, 9:12 AM ET·0001140361-26-018716
- 8-K/A173.6 KBGYRE THERAPEUTICS, INC.Apr 17, 8:55 AM ET·0001140361-26-015307
Insiders
10- BARRETT M JAMESDirector, 10% Owner
- BARRIS PETER J10% Owner
- Bencherif MerouaneVP, Preclinical Research
- Bergmann Joshua BenjaminGC and Corporate Secretary
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- BLIXT CHARLES ADirector
- Blouse Grant E.Chief Scientific Officer
- Brennan Jeffrey PVP - Bus. & Commercial Dev.
- BROWN JULIA RDirector
- BURRILL STEVENDirector
Tickers
Addresses
business
12730 HIGH BLUFF DRIVE SUITE 250
SAN DIEGO, CA, 92130
mailing
12730 HIGH BLUFF DRIVE SUITE 250
SAN DIEGO, CA, 92130
Former Names
- CATALYST BIOSCIENCES, INC.2023-10-27
- TARGACEPT INC2015-08-19